Scantox Group

📍 Lille Skensved, Copenhagen, Denmark🗓 Founded 1977👥 136 employees💰 Last funded Jan 2021
Biotechnology Research🌐 scantox.com
Website LinkedIn
Scantox is a Scandinavian preclinical GLP-accredited Contract Research Organization focused on pharmacology and regulatory toxicology. Based on decades of experience, we are a trusted partner for product development services within the pharmaceutical and medical device industries. The Scantox Group is headquartered in Denmark, with Swedish subsidiaries in Lund, Gothenburg and Solna. Our services enable clients to progress their drug or device development based on solid data to the highest technical and scientific standards. The Scantox team is passionate about our common vision to improve the health of people, and all our processes are rooted in dedication and guided by a strong sense of purpose. Founded in 1977, Scantox is today owned by the Nordic based investment company Impilo. Certified as a 2023 Great Place To Work™. #pharmacology #toxicology #histopathology #pathology #minipigtoxicology
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1977
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Scantox Group?
Scantox Group has 1 investors on record on gritt.io.
When did Scantox Group last raise funding?
The most recent investment in Scantox Group recorded on gritt.io was in January 2021.
When was Scantox Group founded?
Scantox Group was founded in 1977.
What industry is Scantox Group in?
Scantox Group operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Scantox Group based?
Scantox Group is headquartered in Lille Skensved, Copenhagen, Denmark.